Related Experiment Video
Updated: Dec 7, 2025
08:54
Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
Published on: May 8, 2018
14.7K
Adrenal oligometastasis cured with stereotactic ablative radiotherapy
Julia Malone1, Jason R Pantarotto1, David Tiberi1
1Division of Radiation Oncology, University of Ottawa, 501 Smyth Road, Ottawa, Ontario K1H 8L6, Canada.
Radiology Case Reports
|September 28, 2020
Summary
Stereotactic ablative radiotherapy (SABR) offers a noninvasive alternative for adrenal metastases, providing durable local control. This approach can lead to long-term remission and potential cure in select patients with oligometastatic disease.
Area of Science:
- Oncology
- Radiation Oncology
- Surgical Oncology
Background:
- Oligometastatic disease presents a unique challenge in cancer management.
- Adrenalectomies have been a historical treatment for adrenal oligometastases, offering durable local control.
- Stereotactic ablative radiotherapy (SABR) is emerging as a noninvasive alternative to surgery.
